Spots Global Cancer Trial Database for Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
Official Title: Phase 2 Single Agent Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia (GTN)
Study ID: NCT05405192
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to see if Dostarlimab is an effective treatment for Gestational Trophoblastic Neoplasia (GTN).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact Details
Name: Marilyn Huang, MD
Affiliation: University of Miami
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
